Bibliography
- GIACOBINI E: Drugs that target cholinesterases. In: Cognitive Enhancing Drugs. Buccafusco JJ (Ed.). Birkhäuser Verlag, Basel-Boston-Berlin (2004):11-36.
- HOSTETTMANNN K, BORLOZ A, URBAIN A, MARSTON A: Natural product inhibitors of acetylcholinesterase. Curr. Org. Chem. (2006) 10(8):825-847.
- HOUGHTON PJ, REN Y, HOWES M-J: Acetylcholinesterase inhibitors from plants and fungi. Nat. Prod. Rep. (2006) 23(2):181-199.
- NORDBERG A: Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer's disease. Alz. Dis. Assoc. Dis. (2006) 20(2 Suppl. 1):S12-S18.
- DU D-M, CARLIER PR: Development of bivalent acatylcholinesterase inhibitors as potential therapeutic drugs for Alzheimer's disease. Curr. Pharm. Design (2004) 10(25):3141-3156.
- MUNOZ-TORRERO D, CAMPS P: Dimeric and hybrid anti-Alzheimer drug candidates. Curr. Med. Chem. (2006) 13(4):399-422.
- LANE RM, POTKIN SG, ENZ A: Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int. J. Neuropsychopharmacol. (2006) 9(1):101-124.
- DECKER M: Recent advances in the development of hybrid molecules/designed multiple compounds with anti-amnesic properties. Mini-Rev. Med. Chem. (2007) 7(3):221-229.
- YAMAGUCHI Y, HIGASHI M, MATSUNO T, KAWASHIMA S: Ameliorative effects of azaindolizinone derivative ZSET845 on scopolamine-induced deficits in passive avoidance and radial-arm maze learning in the rat. Jpn. J. Pharmacol. (2001) 87(3):240-244.
- EL-KATEB AA, SIDKY MM: Synthesis of certain quinoline derivatives as potential anticholinesterases. Egypt. J. Chem. (1983) 25(3):263-267.
Patents
- HO H, HO D: US20050182044 (2005).
- UNITED STATES GOVERNMENT: WO2006054294 (2006).
- INSA ROUEN et al.: WO2006103120 (2006).
- ShakyaNFatimaZNathCSaxenaAKCouncil of Scientific and Industrial ResearchSubstituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors. Priority date: 28/12/2004. Filing date: 28/12/2004.US2006014233529062006